ArticleNMR in biomedicine2026
From a Voxel to Maps: A Comparative Study of sLASER SVS and 3D-CRT-FID-MRSI at 3 T and 7 T.
Article in NMR in biomedicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Short Echo-Time Spiral MRSI Versus Single-Voxel Spectroscopy in the Human Brain at 3 Tesla With Semi-LASER Localization.Magnetic resonance in medicine · 2026Article
- Mastering preclinical proton and deuterium-based fast MRSI in the brain: from setup to execution.Magma (New York, N.Y.) · 2026Review
Corrections and comments
- Update of
Authors and funding
8 authors.
Funding
Abstract
Magnetic resonance spectroscopy (MRS) enables noninvasive assessment of brain metabolites and is commonly implemented using single-voxel spectroscopy (SVS) or magnetic resonance spectroscopic imaging (MRSI). This study directly compares the reproducibility of single-voxel sLASER and 3D-Concentric Ring Trajectory-based Free Induction Decay MRSI (3D-CRT-FID-MRSI) at 3 T and 7 T in the same cohort. Five healthy adults were each scanned twice on a 3 T PrismaFit (Siemens; 64-channel head coil) and a 7 T MAGNETOM 7 T Plus (Siemens; 32-channel head coil), with sessions 5-9 days apart. To explore MRSI's capabilities for regional metabolite quantification and reproducibility assessment, three masking strategies were applied. Additionally, two spatial averaging approaches for MRSI, averaging before vs. after spectral fitting, were evaluated. Coefficients of variation (CVs) and voxel-wise correlation analyses were used to assess intrasubject and intersession reproducibility. Results showed good-to-excellent reproducibility across both techniques, with SVS generally providing lower CVs at 7 T, while MRSI outperformed SVS in several metabolites at 3 T. MRSI allowed tissue-specific analysis, with lower CVs observed in WM compared to GM, especially at 7 T. Although MRSI reproducibility was slightly reduced at 7 T likely due to longer scan times and lack of prospective motion correction at 7 T (which was available at 3 T in this study), the spatial coverage and retrospective region analysis makes it an attractive alternative to SVS for many brain regions. This study demonstrates that both sLASER and CRT-FID-MRSI provide reproducible metabolite measurements at 3 T and 7 T. The findings highlight MRSI's advantages for retrospective multiregional and tissue-specific analysis, facilitating its integration into future clinical research.
Indexed as
Identifiers
41321025What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.